UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029649
Receipt number R000033877
Scientific Title Prospective observational study for elderly people assessment tool for patients with resectable stage thoracic esophageal squamous cell carcinoma of the elderly (over 70 years old)
Date of disclosure of the study information 2018/01/01
Last modified on 2022/08/16 14:42:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective observational study for elderly people assessment tool for patients with resectable stage thoracic esophageal squamous cell carcinoma of the elderly (over 70 years old)

Acronym

Elderly esophageal cancer prospective observation

Scientific Title

Prospective observational study for elderly people assessment tool for patients with resectable stage thoracic esophageal squamous cell carcinoma of the elderly (over 70 years old)

Scientific Title:Acronym

Elderly esophageal cancer prospective observation

Region

Japan


Condition

Condition

Thoracic esophageal squamous cell carcinoma

Classification by specialty

Medicine in general Gastroenterology Geriatrics
Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In this study, we conducted an elderly assessment for elderly patients with resectable thoracic esophageal squamous cell carcinoma (UICC 7 version: Stage II / III excluding T4) and were able to resect each of the thoracic esophageal squamous cell carcinomas in clinical stage. It is to gather basic data of the assessment tool and clarify the screening situation of treatment. We also explore the relationship between the elderly assessment and the adverse events and turning points of the selected treatment.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Incidence of serious adverse event

Key secondary outcomes

Survival by treatment group, survival by elderly people assessment, percentage of adverse events by elderly people assessment


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) over 70 years old
2) Pathologically proven squamous cell carcinoma of thoracic esophageal squamous cell carcinoma
3) Clinical stage cStage IB / II / III (excluding T4) in TNM classification (UICC-TNM 7th edition).
(Ut, Mt, Lt has tumor-major occupation site, permits infiltration into the neck and abdomen)
4) First treatment scheduled to be implemented at the institution
5) Consent has been obtained in the sentences of the subject person or of an adult family member

Key exclusion criteria

None

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name Kitagawa

Organization

Keio University, School of Medicine

Division name

Keio Cancer Center

Zip code

1608582

Address

35, Shinanamachi, Shinjukuku, Tokyo, Japan

TEL

03-3353-1211

Email

kitagawa@a3.keio.jp


Public contact

Name of contact person

1st name Yasuo
Middle name
Last name Hamamoto

Organization

Keio University, school of medicine

Division name

Keio Cancer Center

Zip code

1608582

Address

35, Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Homepage URL


Email

yashmmt1971@gmail.com


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

35, Shinanomachi, Shinjukuku, Tokyo, Japan

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学医学部 腫瘍センター


Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results

None

Results date posted

2022 Year 08 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 04 Month 22 Day

Date of IRB

2017 Year 08 Month 07 Day

Anticipated trial start date

2018 Year 08 Month 07 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry

2025 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded

2025 Year 12 Month 31 Day


Other

Other related information

None


Management information

Registered date

2017 Year 10 Month 21 Day

Last modified on

2022 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033877


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2022/08/16 E-choice:解析データ(固定用データ)20220802.xlsx